The shorts did not cover and now they are increasing if what you say is true it certainly is professional. They were/are very sure of themselves! The AdComm attack and then the lawsuits seemed planned. So what is the end game? No FDA approval of Rexista until more testing and the share price drops again while IPCI scrambles for operational capital seems to be obvious. The CFO resigning really bothered me because he left at such a bad time. Laugh if you will but I am hoping that Odidi represents a beacon of hope/pride... and that a few wealthy entities will help to advance his science. This company needs help.
News 
Market Data 
Discover 
AI
